N
NUVB
Nuvation Bio Inc
6.07
-0.21-3.34%After Hours: 6.06 -0.01 -0.16%18:15 09/11 EDT
OPEN/PREV CLOSE6.36/6.28
TODAY RANGE5.95-6.39
VOL4.32M
MARKET CAP2.13B
52 WEEK RANGE2.990-9.75
AVG VOL (3M)6.72M
% TURNOVER1.23%
TURNOVER--
P/E (TTM)-13.9508
% RANGE7.01%
EPS(TTM)-0.4351
P/E(FORWARD)-16.1479
P/B8.36
BVPS0.7257
DIVIDEND--
P/S33.44
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP1.76B
SHARES OUTSTANDING351.12M
NEXT EARNINGS11/02-11/06
FREE FLOAT290.65M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Simply Wall St·2d ago
Is Nuvation Bio (NUVB) Undervalued As Investors Weigh Its Glioma Growth Story?
Simply Wall St·5d ago
Nuvation Bio (NUVB) Stock Looks Stretched Despite Its 354% Three Year Run
Benzinga·09/04 11:07
Jim Cramer: This Health Care Stock Is Pure Spec, The Only Neocloud I Like Is...
Simply Wall St·09/03 22:28
Nuvation Bio (NUVB) Wins FDA Fast Track Status, Is The Stock Still Undervalued?
PR Newswire·09/02 20:05
Nuvation Bio to Participate in Upcoming Investor Conferences
Seeking Alpha·08/26 20:15
Nuvation: Why I'm Downgrading To Hold Despite Progress On NSCLC And Glioma Fronts
Simply Wall St·08/26 05:25
How Safusidenib’s FDA Fast Track Status Could Impact Nuvation Bio (NUVB) Investors
Simply Wall St·08/23 11:16
Nuvation Bio (NUVB) Gains Fast Track Backing As Fair Value Stays In Focus
Seeking Alpha·08/22 21:57
SA Asks: What are the most promising oncology companies right now?
Seeking Alpha·08/21 15:10
Nuvation Bio rises as Cantor initiates at overweight
Benzinga·08/21 15:08
This Teradyne Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
Benzinga·08/21 14:29
This Equifax Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday
Benzinga·08/21 11:46
This Nvidia Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Benzinga·08/21 10:14
Cantor Fitzgerald Initiates Coverage On Nuvation Bio with Overweight Rating
Same Industry
Name/Symbol
Change%
Price